Stock Analysis on Net
Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Shockwave Medical Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Accounts payable 0.57 1.04 1.02 0.54 1.20
Debt, current portion 0.00 0.00 1.59 1.21 2.87
Employee compensation 3.17 5.09 7.45 4.00 3.51
Asset purchases 0.50 0.71 1.19 0.93 0.00
Professional services 0.40 0.63 0.76 0.49 0.35
Research and development costs 0.52 0.62 1.33 1.12 1.33
Excise, sales, income and other taxes 0.79 0.62 0.36 0.00 0.00
Sales and marketing 0.22 0.31 0.00 0.00 0.00
Other 0.26 0.59 0.74 0.79 0.75
Accrued liabilities 5.85% 8.57% 11.82% 7.33% 5.94%
Operating lease liability, current portion 0.23 0.20 0.50 0.32 0.33
Current liabilities 6.65% 9.81% 14.94% 9.40% 10.35%
Operating lease liability, noncurrent portion 2.24 5.41 8.19 2.75 3.50
Convertible debt, noncurrent portion 46.72 0.00 0.00 0.00 0.00
Debt, noncurrent portion 0.00 3.75 3.36 4.90 3.08
Related party contract liability, noncurrent portion 0.78 1.90 3.55 0.00 0.00
Deferred tax liabilities 0.23 0.00 0.00 0.00 0.00
Long-term income tax liability 0.10 0.00 0.00 0.00 0.00
Other liabilities 0.59 0.00 0.00 0.00 0.00
Noncurrent liabilities 50.66% 11.05% 15.11% 7.65% 6.59%
Total liabilities 57.32% 20.86% 30.04% 17.05% 16.94%
Preferred stock, $0.001 par value per share; no shares issued and outstanding 0.00 0.00 0.00 0.00 0.00
Common stock, $0.001 par value per share 0.00 0.01 0.01 0.01 0.01
Additional paid-in capital 35.61 84.97 143.14 172.50 159.77
Accumulated other comprehensive income (loss) 0.02 -0.13 -0.06 0.00 0.02
Retained earnings (accumulated deficit) 7.05 -5.70 -73.13 -89.57 -76.73
Stockholders’ equity 42.68% 79.14% 69.96% 82.95% 83.06%
Total liabilities and stockholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Shockwave Medical Inc. current liabilities as a percentage of total liabilities and stockholders’ equity decreased from 2021 to 2022 and from 2022 to 2023.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Shockwave Medical Inc. noncurrent liabilities as a percentage of total liabilities and stockholders’ equity decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Shockwave Medical Inc. total liabilities as a percentage of total liabilities and stockholders’ equity decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Shockwave Medical Inc. stockholders’ equity as a percentage of total liabilities and stockholders’ equity increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.